Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-07 · accession 0001493152-24-023288 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-07 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $2.12 | +2,500 | 285.8K | +0.9% | +$5,300 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-07 | P | A | 2,500 | $2.12 | 285,834 | D | — | — |